Cellbricks Therapeutics is a series b startup. 1 investor tracked. Status: possibledead.
Cellbricks Therapeutics is a company headquartered in Germany. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
Cellbricks Therapeutics focuses on developing 3D-printed human tissues for pharmaceutical research and regenerative medicine.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.